ALRTF supply chain intelligence for ALR Technologies SG Ltd.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
ALR Technologies SG Ltd. (ALRTF) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| ALRT-DELAWARE-INC | ALRT-DELAWARE-INC | 62% | hermore, we may expect to require clearance of similar regulatory authorities abroad to market our Diabetes Solution products with CGM or BGM for human use. Our products for human health are subject … |
| CANADA-LTD | CANADA-LTD | 62% | assessments for work related accidents. In 1993 Dr. Salas was appointed Director of the Medical Service Plan of Colombia, serving in that capacity until 1995 and, during that period and with a suppor… |
| CGM-MEDICAL-TECHNOLOGY-SHEN-ZHEN-LTD | CGM-MEDICAL-TECHNOLOGY-SHEN-ZHEN-LTD | 62% | placed on the pet in minutes, after which they are sent home, greatly reducing the time spent by the staff during an in-clinic glucose curve of caring for the pet and manually drawing blood and recor… |
| CHINA-ONE-CORPORATION | CHINA-ONE-CORPORATION | 62% | assessments for work related accidents. In 1993 Dr. Salas was appointed Director of the Medical Service Plan of Colombia, serving in that capacity until 1995 and, during that period and with a suppor… |
| KAISER-RESOURCES-LTD | KAISER-RESOURCES-LTD | 62% | assessments for work related accidents. In 1993 Dr. Salas was appointed Director of the Medical Service Plan of Colombia, serving in that capacity until 1995 and, during that period and with a suppor… |
| KAN-WAN-CHEN-PTE-LTD | KAN-WAN-CHEN-PTE-LTD | 62% | berta. The financial results and position of foreign operations whose functional currency is different from the presentation currency are translated as follows: · Assets and liabilities are translate… |
| NISSHO-IWAI-CORP | NISSHO-IWAI-CORP | 62% | assessments for work related accidents. In 1993 Dr. Salas was appointed Director of the Medical Service Plan of Colombia, serving in that capacity until 1995 and, during that period and with a suppor… |
| OTC-MARKETS-GROUP-INC | OTC-MARKETS-GROUP-INC | 62% | hermore, we may expect to require clearance of similar regulatory authorities abroad to market our Diabetes Solution products with CGM or BGM for human use. Our products for human health are subject … |
| PASSIVE-FOREIGN-INVESTMENT-COMPANY | PASSIVE-FOREIGN-INVESTMENT-COMPANY | 62% | tion by any of them of shares in a company, to obtain or consolidate effective control of that company. Certain persons are presumed (unless the presumption is rebutted) to be acting in concert with … |
| PIKES-PEAK-RESOURCES-INC | PIKES-PEAK-RESOURCES-INC | 62% | assessments for work related accidents. In 1993 Dr. Salas was appointed Director of the Medical Service Plan of Colombia, serving in that capacity until 1995 and, during that period and with a suppor… |
| RUSSELL-BREWERIES-INC | RUSSELL-BREWERIES-INC | 62% | assessments for work related accidents. In 1993 Dr. Salas was appointed Director of the Medical Service Plan of Colombia, serving in that capacity until 1995 and, during that period and with a suppor… |
| SECURITIES-DEALERS-INC | SECURITIES-DEALERS-INC | 62% | hermore, we may expect to require clearance of similar regulatory authorities abroad to market our Diabetes Solution products with CGM or BGM for human use. Our products for human health are subject … |
| TRICOR-SINGAPORE-PTE-LTD | TRICOR-SINGAPORE-PTE-LTD | 62% | hermore, we may expect to require clearance of similar regulatory authorities abroad to market our Diabetes Solution products with CGM or BGM for human use. Our products for human health are subject … |
| U-S-HOLDINGS | U-S-HOLDINGS | 62% | hermore, we may expect to require clearance of similar regulatory authorities abroad to market our Diabetes Solution products with CGM or BGM for human use. Our products for human health are subject … |
| VISTRA-GROUP | VISTRA-GROUP | 62% | hermore, we may expect to require clearance of similar regulatory authorities abroad to market our Diabetes Solution products with CGM or BGM for human use. Our products for human health are subject … |
| VST | Vistra Corp. | 62% | Reciprocal relationship from VST graph: Reciprocal relationship from ALRTF graph: Reciprocal relationship from VST graph: Reciprocal relationship from ALRTF graph: Reciprocal relationship from VST gr… |
| WEX-PHARMACEUTICALS-INC | WEX-PHARMACEUTICALS-INC | 62% | assessments for work related accidents. In 1993 Dr. Salas was appointed Director of the Medical Service Plan of Colombia, serving in that capacity until 1995 and, during that period and with a suppor… |
| Instrument | Description | Confidence | Evidence |
|---|---|---|---|
| ALRTF-DEBT | Debt stack $32.3M | 90% | Market cache reports total debt of $32.3M. |
| ALRTF-DEBT-7694 | Warrants outstanding: 0.004 | 90% | xbrl warrant detail from xbrl 2023-12-31. |
| ALRTF-DEBT-7695 | Xbrl Convertible | 90% | xbrl convertible detail from xbrl 2022-12-31. |